Immunogenic proteins and compositions for the treatment and prevention of Streptococcus agalactiae

Details for Australian Patent Application No. 2011234031 (hide)

Owner Novartis AG

Inventors Grandi, Guido; Maione, Domenico; Rinuado, Cira Daniela

Agent FB Rice

Pub. Number AU-A-2011234031

PCT Pub. Number WO2011/121576

Priority 1005625.7 01.04.10 GB

Filing date 1 April 2011

Wipo publication date 6 October 2011

International Classifications

C07K 14/315 Peptides having more than 20 amino acids

A61K 39/00 Medicinal preparations containing antigens or antibodies

A61K 39/09 Medicinal preparations containing antigens or antibodies - Streptococcus

C07K 16/12 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

Event Publications

25 October 2012 PCT application entered the National Phase

  PCT publication WO2011/121576 Priority application(s): WO2011/121576

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011234040-Methods and apparatus for reducing count of infectious agents in intravenous access systems

2011234028-Treatment of tantalumand/or niobium-containing compounds